Cargando…

Compassionate Use of Avacopan in Difficult-to-Treat Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

Detalles Bibliográficos
Autores principales:	van Leeuwen, Jolijn R., Bredewold, Obbo W., van Dam, Laura S., Werkman, Stella L., Jonker, Jacqueline T., Geelhoed, Miranda, Langeveld, Antonius P.M., Remmelts, Hilde H.F., van den Broecke, Maud M., Ray, Argho, Rabelink, Ton J., Teng, Y.K. Onno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897689/ https://www.ncbi.nlm.nih.gov/pubmed/35257076 http://dx.doi.org/10.1016/j.ekir.2021.11.036

Ejemplares similares

Response to “Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Autoantibody-Associated Renal Vasculitis and Concominant Complement System Activation”
por: van Leeuwen, Jolijn R., et al.
Publicado: (2022)

Preliminary Assessment of Safety and Tolerability of Avacopan During the Early Access Program for ANCA-Associated Vasculitis
por: van Leeuwen, Jolijn R, et al.
Publicado: (2023)

ExploriNg DUrable Remission with Rituximab in ANCA-associatEd vasculitis (ENDURRANCE trial): protocol for a randomised controlled trial
por: Dirikgil, Ebru, et al.
Publicado: (2022)

Clinical Practice Audit on the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in the Netherlands
por: Dirikgil, Ebru, et al.
Publicado: (2021)

A case of mononucleosis infectiosa presenting with cholemic nephrosis
por: Bredewold, Obbo W., et al.
Publicado: (2011)

PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab
por: van Dam, Laura S, et al.
Publicado: (2020)

Avacopan as First-Line Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Steroid-Sparing Option
por: Gabilan, Charlotte, et al.
Publicado: (2022)

Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year results
por: Kraaij, Tineke, et al.
Publicado: (2020)

TAC-TIC use of tacrolimus-based regimens in lupus nephritis
por: Kraaij, Tineke, et al.
Publicado: (2016)

Adjunctive Treatment With Avacopan, an Oral C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
por: Merkel, Peter A., et al.
Publicado: (2020)

Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Antibody-Associated Renal Vasculitis and Concominant Complement System Activation
por: Hakroush, Samy, et al.
Publicado: (2022)

Clinical Implications of Excessive Neutrophil Extracellular Trap Formation in Renal Autoimmune Diseases
por: van Dam, Laura S., et al.
Publicado: (2018)

Intrinsically Distinct Role of Neutrophil Extracellular Trap Formation in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Compared to Systemic Lupus Erythematosus
por: van Dam, Laura S., et al.
Publicado: (2019)

The impact of reclassification by the 2022 ACR/EULAR classification criteria on risk factors for relapse in patients with ANCA-associated vasculitis
por: van Leeuwen, Jolijn R, et al.
Publicado: (2023)

Avacopan in Patients With Rapidly Progressive Glomerulonephritis Requiring Dialysis
por: Cortazar, Frank B., et al.
Publicado: (2023)

Avacopan/methylprednisolone/prednisone: Various toxicities: 8 case reports
Publicado: (2022)

Journal Club Review of “Avacopan for the Treatment of ANCA‐Associated Vasculitis”
por: Soulsby, William Daniel
Publicado: (2022)

Outcomes of COVID-19 in patients with ANCA-associated vasculitis receiving avacopan
por: Aqeel, Faten, et al.
Publicado: (2023)

Renal improvement and remission in a patient with refractory ANCA-associated vasculitis treated with avacopan
por: Alvarez, Luis, et al.
Publicado: (2023)

Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients
por: van Dam, Laura S., et al.
Publicado: (2020)

C5a receptor inhibitor avacopan in immunoglobulin A nephropathy—an open-label pilot study
por: Bruchfeld, Annette, et al.
Publicado: (2022)

Avacopan improves patient perspective on steroid-related toxicity effects in a case with ANCA-associated vasculitis
por: Korsten, Peter, et al.
Publicado: (2023)

Antineutrophil cytoplasmic antibodies in infective endocarditis: a case report and systematic review of the literature
por: Van Gool, Inge C., et al.
Publicado: (2022)

Evaluation of the Safety and Efficacy of Avacopan, a C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Treated Concomitantly With Rituximab or Cyclophosphamide/Azathioprine: Protocol for a Randomized, Double-Blind, Active-Controlled, Phase 3 Trial
por: Merkel, Peter A, et al.
Publicado: (2020)

Compassionate Counterterrorism
por: Olaimy, Leena
Publicado: (2019)

Compassionate Care
por: Post, Stephen G., et al.
Publicado: (2012)

Compassionate Conversations
por: Gardner, Sharryn, et al.
Publicado: (2014)

Building Compassionate Experience Through Compassionate Action: Qualitative Behavioral Analysis
por: Desveaux, Laura, et al.
Publicado: (2023)

Rapid and discriminatory diagnosis of scrapie and BSE in retro-pharyngeal lymph nodes of sheep
por: Langeveld, Jan PM, et al.
Publicado: (2006)

The teachings of the compassionate Buddha
Publicado: (1955)

The Compassionate and Forgiving Organization
por: Lennick, Doug
Publicado: (2010)

Compassionate ethics for clinics
por: Kim, Tae-Il
Publicado: (2013)

Compassionate Health Care
por: Malliarou, Maria
Publicado: (2022)

Measuring compassionate healthcare with the 12-item Schwartz Center Compassionate Care Scale
por: Rodriguez, Ana Maria, et al.
Publicado: (2019)

Interdependent = Compassionate? Compassionate and Self-Image Goals and Their Relationships With Interdependence in the United States and Japan
por: Niiya, Yu, et al.
Publicado: (2019)

Implementation Models of Compassionate Communities and Compassionate Cities at the End of Life: A Systematic Review
por: Librada-Flores, Silvia, et al.
Publicado: (2020)

Correction: Measuring compassionate healthcare with the 12-item Schwartz Center Compassionate Care Scale
por: Rodriguez, Ana Maria, et al.
Publicado: (2019)

The measurement of compassionate leadership: Adaptation and Spanish validation of the compassionate leadership self‐reported scale
por: Sansó, Noemí, et al.
Publicado: (2022)

Antineutrophil cytoplasmic antibodies in myelodysplasia.
por: Hull, D. R., et al.
Publicado: (1996)

Compassionate use of cell products
por: de Santis, Gil Cunha, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_g5po9qscm8s9t3uicf5sc78tqf